W.P. Carey faces market reaction as Q4 FY23 earnings reveal a revenue increase to $412.4 million but a decline in AFFO per share to $1.19 due to spin-off impacts.
Companies Reporting Before The Bell
• Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.